WBBJ TV
May 19, 2021
MEMPHIS, Tenn. Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center in Memphis are enrolling pediatric volunteers in a clinical trial for a COVID-19 antibody treatment, according to a news release.
The release says volunteers should be children and adolescents up to 18-years-old. The trial will look at how these volunteers respond to Regeneron’s investigational antibody treatment REGEN-COV, the release says.
The treatment has been approved for emergency use, according to the release.
Recruitment of patients quickly after their first positive COVID-19 test is critical, the release syas.
For more information on the clinical trial and how to enroll, click here.
Researchers receive $4 5 million grant to improve quality of care for people with cardiovascular disease news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Credit: UTHSC
Memphis, Tenn. (May 17, 2021) - Researchers from the University of Tennessee Health Science Center have received a $4.5 million grant over three years from the Agency for Healthcare Research and Quality (AHRQ) to lead a statewide network of primary care providers, health systems, and academic centers to identify, develop, and implement patient-centered approaches to improve quality of care and outcomes for people with cardiovascular disease. Tennessee is one of only four states in the country chosen by AHRQ to receive this grant and create a statewide heart health network.
The Tennessee Heart Health Network will identify evidence-based interventions to aid primary care providers across the state in treating cardiovascular disease, the main cause of premature morbidity and mortality in the United States. The initiative will focus on hypertension control and smoking cessation as the two primary modifiable risk factors for cardiovascular disease and will help primary car
The Clinical Trials Network of Tennessee (CTN2) at the University of Tennessee Health Science Center has contracted a new clinical trial to test possible therapeutics for COVID-19 in hospitalized patients. This new trial brings the total generated by CTN2 contracts for the university to nearly $7 million.
Dr Veronica Mallett named CEO of Meharry Medical College Ventures - Nashville Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.